← Back to Search

HLWD for Type 2 Diabetes

N/A
Waitlist Available
Led By Olayinka Shiyanbola, MD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 2 months, 6 months
Awards & highlights

Study Summary

This trial is testing whether a new diabetes self-management program is more effective than the existing program.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 2 months, 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2 months, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in blood glucose (hemoglobin A1C)
Secondary outcome measures
Acceptability of intervention
Adherence to Refills and Medicines Scale for Diabetes (ARMS-D) Score
Feasibility of intervention
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Peers EXCELExperimental Treatment2 Interventions
Participants will have an 8-week self-management program, and will participate in phone calls with a peer for the remaining 4 months.
Group II: Healthy Living with Diabetes (HLWD)Active Control1 Intervention
Participants will have a 6-week self-management program, followed by the option to work with a Community Health Worker for the remaining 4 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peers LEAD
2023
N/A
~20
HLWD
2023
N/A
~20

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,193 Previous Clinical Trials
3,161,926 Total Patients Enrolled
Olayinka Shiyanbola, MDPrincipal InvestigatorUniversity of Wisconsin, Madison
~6 spots leftby Jun 2025